Located in Laval, Moderna’s 9,590 m2 production facility for mRNA vaccines has capacity to produce 100 million doses annually.
In just 15 months, EXP’s multidisciplinary teams provided critical engineering for and supported construction of Moderna’s first Canadian production facility for mRNA vaccines. This accomplishment helped reach an important milestone for Moderna in Canada – further supporting disease treatment and prevention.
EXP’s team provided multidisciplinary engineering services, preparing technical documents related to mechanical, electrical, civil and structural engineering and provided construction supervision. Our team’s work covered manufacturing, cleaning, warehouse, shipping and receiving, administrative spaces, as well as laboratories, HVAC systems and automation support.
Innovative use of sustainable technologies and design
This project stands out for its innovative application of sustainable and energy-efficient technologies for pharmaceutical facilities and laboratories. EXP proposed innovative engineering solutions to support Moderna in reaching its sustainable objectives, including net-zero emissions. Solutions included the installation of heat recovery systems with heat pumps to heat buildings and using heat recovery chillers to recover heat generated by the process cooling system during the winter months. This efficient system could potentially reduce energy use by up to 50%.
Adiabatic humidifiers were integrated into the design to further reduce energy consumption. The high efficiency plumbing system contributes a 20% increase in water savings compared to traditional systems, while mechanical motor control with frequency converters and lighting management throughout the building significantly reduce overall energy consumption.
Images © Stéphane Brügger
Services
Mechanical, Electrical, Structural, Civil, Energy Efficiency and Optimization, LEED Consultation, Sustainability, Industrial Process, Fire Protection, BIM/Digital Delivery, Construction Supervision